Ausgabe 1/2014
Inhalt (40 Artikel)
Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review
S. Nayak, D. L. Edwards, A. A. Saleh, S. L. Greenspan
A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures
L. Si, T. M. Winzenberg, A. J. Palmer
FRAX provides robust fracture prediction regardless of socioeconomic status
S. L. Brennan, W. D. Leslie, L. M. Lix, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis
The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease
S. A. Jamal, S. L. West, T. L. Nickolas
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial
D. Prieto-Alhambra, A. Judge, N. K. Arden, C. Cooper, K. W. Lyles, M. K. Javaid
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study
C. L. Gregson, E. M. Dennison, J. E. Compston, S. Adami, J. D. Adachi, F. A. Anderson Jr, S. Boonen, R. Chapurlat, A. Díez-Pérez, S. L. Greenspan, F. H. Hooven, A. Z. LaCroix, J. W. Nieves, J. C. Netelenbos, J. Pfeilschifter, M. Rossini, C. Roux, K. G. Saag, S. Silverman, E. S. Siris, N. B. Watts, A. Wyman, C. Cooper
Association between hypertension and fragility fracture: a longitudinal study
S. Yang, N. D. Nguyen, J. R. Center, J. A. Eisman, T. V. Nguyen
Association between use of benzodiazepines and risk of fractures: a meta-analysis
D. Xing, X. L. Ma, J. X. Ma, J. Wang, Y. Yang, Y. Chen
β-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects
K. A. Toulis, K. Hemming, S. Stergianos, K. Nirantharakumar, J. P. Bilezikian
Low holotranscobalamin and cobalamins predict incident fractures in elderly men: the MrOS Sweden
C. Lewerin, H. Nilsson-Ehle, S. Jacobsson, H. Johansson, V. Sundh, M. K. Karlsson, Ö. Ljunggren, M. Lorentzon, J. A. Kanis, U. H. Lerner, S. R. Cummings, C. Ohlsson, D. Mellström
Coffee, tea, and the risk of hip fracture: a meta-analysis
J. Sheng, X. Qu, X. Zhang, Z. Zhai, H. Li, X. Liu, H. Li, G. Liu, Z. Zhu, Y. Hao, A. Qin, K. Dai
Fracture risk following bariatric surgery: a population-based study
K. M. Nakamura, E. G. C. Haglind, J. A. Clowes, S. J. Achenbach, E. J. Atkinson, L. J. Melton III, K. A. Kennel
Incidence and risk factors for hip fractures in dialysis patients
M. Maravic, A. Ostertag, P. U. Torres, M. Cohen-Solal
Gender-specific hip fracture risk in community-dwelling and institutionalized seniors age 65 years and older
M. Finsterwald, E. Sidelnikov, E. J. Orav, B. Dawson-Hughes, R. Theiler, A. Egli, A. Platz, H. P. Simmen, C. Meier, D. Grob, S. Beck, H. B. Stähelin, H. A. Bischoff-Ferrari
Exploring the determinants of fracture risk among individuals with spinal cord injury
D. Lala, B. C. Craven, L. Thabane, A. Papaioannou, J. D. Adachi, M. R. Popovic, L. M. Giangregorio
Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults
D. Scott, A. Hayes, K. M. Sanders, D. Aitken, P. R. Ebeling, G. Jones
Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation
D. A. Eekman, M. M. ter Wee, V. M. H. Coupé, S. Erisek-Demirtas, M. H. Kramer, W. F. Lems
Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provinces
R. G. Crilly, M. Kloseck, B. Chesworth, S. Mequanint, E. Sadowski, J. Gilliland
Epidemiology of fractures in Iceland and secular trends in major osteoporotic fractures 1989–2008
K. Siggeirsdottir, T. Aspelund, B. Y. Jonsson, B. Mogensen, E. F. Gudmundsson, V. Gudnason, G. Sigurdsson
Erratum to: Epidemiology of fractures in Iceland and secular trends in major osteoporotic fractures 1989–2008
K. Siggeirsdottir, T. Aspelund, B. Y. Jonsson, B. Mogensen, E. F. Gudmundsson, V. Gudnason, G. Sigurdsson
Effect of increased fruit and vegetable consumption on bone turnover in older adults: a randomised controlled trial
C. E. Neville, I. S. Young, S. E. C. M. Gilchrist, M. C. McKinley, A. Gibson, J. D. Edgar, J. V. Woodside
Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures
H. Johansson, A. Odén, E. V. McCloskey, J. A. Kanis
Added value of trabecular bone score over bone mineral density for identification of vertebral fractures in patients with areal bone mineral density in the non-osteoporotic range
K. Nassar, S. Paternotte, S. Kolta, J. Fechtenbaum, C. Roux, K. Briot
Distribution of bone density and cortical thickness in the proximal femur and their association with hip fracture in postmenopausal women: a quantitative computed tomography study
L. Yang, W. J. M. Udall, E. V. McCloskey, R. Eastell
Physical activity as determinant of femoral neck strength relative to load in adult women: findings from the hip strength across the menopause transition study
T. Mori, S. Ishii, G. A. Greendale, J. A. Cauley, B. Sternfeld, C. J. Crandall, W. Han, A. S. Karlamangla
Is lower income associated with an increased likelihood of qualification for treatment for osteoporosis in Canadian women?
S. L. Brennan, W. D. Leslie, L. M. Lix
Non-pharmacological strategies used by patients at high risk for future fracture to manage fracture risk—a qualitative study
J. E. M. Sale, M. A. Gignac, G. Hawker, D. Beaton, E. Bogoch, F. Webster, L. Frankel, V. Elliot-Gibson
Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy’s fracture clinic screening program
D. E. Beaton, S. Dyer, D. Jiang, R. Sujic, M. Slater, J. E. M. Sale, E. R. Bogoch
The Auckland calcium study: 5-year post-trial follow-up
L. T. Radford, M. J. Bolland, B. Mason, A. Horne, G. D. Gamble, A. Grey, I. R. Reid
A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity?
A. D. Wood, K. R. Secombes, F. Thies, L. S. Aucott, A. J. Black, D. M. Reid, A. Mavroeidi, W. G. Simpson, W. D. Fraser, H. M. Macdonald
Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass
J. Zhang, E. Delzell, J. R. Curtis, F. Hooven, S. H. Gehlbach, F. A. Anderson Jr., K. G. Saag
Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm
K. Kim, A. Svedbom, X. Luo, S. Sutradhar, J. A. Kanis
The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis
P. Hadji, D. Felsenberg, M. Amling, L. C. Hofbauer, J. A. Kandenwein, A. Kurth
Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies
P. D. Miller, R. R. Recker, S. Harris, S. Silverman, D. Felsenberg, J. Reginster, B-M. Day, C. Barr, D. Masanauskaite
Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trial
C. Meier, C. Kraenzlin, N. F. Friederich, T. Wischer, L. Grize, C. R. Meier, M. E. Kraenzlin
Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis—a double-blind, randomized, dose-finding study
T. Nakamura, M. Shiraki, M. Fukunaga, T. Tomomitsu, A. C. Santora, R. Tsai, G. Fujimoto, M. Nakagomi, H. Tsubouchi, E. Rosenberg, S. Uchida
An algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatide
R. Niimi, T. Kono, A. Nishihara, M. Hasegawa, A. Matsumine, T. Nakamura, T. Kono, A. Sudo
Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
C. Klop, F. de Vries, T. Vinks, M. J. Kooij, T. P. van Staa, J. W. J. Bijlsma, A. C. G. Egberts, M. L. Bouvy
Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab
A. Neuprez, S. Coste, E. Rompen, J. M. Crielaard, J. Y. Reginster